1 – 9 of 9
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort
(
- Contribution to journal › Article
-
Mark
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity : Findings from the EMAS cohort
(
- Contribution to journal › Article
-
Mark
Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men : The European Male Ageing Study.
(
- Contribution to journal › Article
- 2021
-
Mark
Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress—Prevalence and Clinical Correlates : Results From the European Male Ageing Study
(
- Contribution to journal › Article
-
Mark
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)
(
- Contribution to journal › Article
- 2018
-
Mark
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism : Prospective results from the EMAS
(
- Contribution to journal › Article
- 2017
-
Mark
Glycemia but not the Metabolic Syndrome is Associated with Cognitive Decline : Findings from the European Male Ageing Study
(
- Contribution to journal › Article
-
Mark
Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study
(
- Contribution to journal › Article
- 2010
-
Mark
Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: the European Male Ageing Study
(
- Contribution to journal › Article